Foresight Diagnostics is the world’s most sensitive liquid biopsy minimal residual disease (MRD) test that detects the earliest hints of cancer relapse.

Biotechnology

Foresight Diagnostics

Foresight Diagnostics' headquarters in Aurora, CO, United States

Jake Chabon

Wendy Yee

Ruben Gutierrez

Suzanne Andrews

John Truesdell

Laura Hyland

Sandy Close

Stanley Lapidus

David Kurtz

Christopher R. Flowers

Maximilian Diehn

Mark Lee

Shahram Seyedin-Noor

Jeff Bird

Sandra Horning

Ash Alizadeh

The Scientific Advisors team at Foresight Diagnostics comprises esteemed experts dedicated to guiding research and development efforts. They provide critical insights on cutting-edge diagnostic technologies, ensuring that the liquid biopsy tests meet the highest scientific standards for sensitivity and reliability. Their expertise helps shape clinical strategies, support regulatory interactions, and propel innovative solutions for early cancer relapse detection.

Scientific Advisors

The Scientific Research and Development team at Foresight Diagnostics focuses on advancing liquid biopsy technologies to enhance the sensitivity and accuracy of cancer relapse detection. This interdisciplinary team conducts innovative research, develops and optimizes in-vitro diagnostic assays, and translates scientific findings into clinically applicable solutions, ensuring the continuous improvement of their minimal residual disease testing capabilities.

Scientific Research and Development

The Business Development and Operations team at Foresight Diagnostics is responsible for identifying growth opportunities, establishing strategic partnerships, and optimizing operational efficiency to support the commercialization of their cutting-edge liquid biopsy technology. This team collaborates across departments to enhance financial performance, streamline laboratory processes, and drive awareness of their MRD testing solutions, ultimately aiming to improve patient outcomes in cancer care.

Business Development and Operations

The Leadership Team at Foresight Diagnostics is responsible for setting the strategic vision and operational direction of the company. Led by the CEO and CSO, this team drives innovation in liquid biopsy technology, ensures alignment of corporate goals, and fosters collaboration across departments to enhance the development and delivery of cutting-edge cancer detection solutions. Their collective expertise guides the company in navigating the competitive landscape and advancing its mission to transform cancer care through early detection.

Foresight Diagnostics

Org chart

Board & advisors

Teams

Scientific Advisors

Scientific Research and Development

Business Development and Operations

Leadership Team

Offices

Foresight Diagnostics

Org chart

Board & advisors

Teams

Scientific Advisors

Scientific Research and Development

Business Development and Operations

Leadership Team

Offices

Related companies